INCY — Incyte Corporation

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Incyte Corporation

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF), polycythemia vera, and steroid-refractory acute graft-versus-host disease; ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; MONJ… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$97.34
Market Cap$19.46B
Float167.8M
Shares Outstanding199.8M
P/E (Forward)12.66
P/E (TTM)13.76
Price/Sales (TTM)3.63
vs. Analyst Target+11.3% to analyst PT
Profit Margin26.71%
Operating Margin (TTM)25.55%
Revenue (TTM)$5.36B
Earnings Growth (YoY)83.80%
Dividend RateNone
Analyst Target Price$108.35 (27 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $2.67B -$296M $2.51B -$178M
2021 $2.99B $949M $2.80B $630M
2022 $3.39B $341M $3.14B $600M
2023 $3.70B $598M $3.38B $919M
2024 $4.24B $32.6M $3.86B $408M
2025 $5.14B $1.29B $4.70B $1.76B

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $1.22B $405M
Sep 2025 $1.37B $424M
Dec 2025 $1.51B $299M
Mar 2026 $1.27B $303M

Ownership & Float

Insider Ownership1.9%
Institutional Ownership106.6%
Short Float6.8%
% of All Funds Holding9.26%
Number of Funds Holding761

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$96.00Near-term / short-term trend
Weekly40-Week SMA$96.30Medium-term trend
Weekly80-Week SMA$82.68Cyclical trend (business cycle)
Weekly200-Week SMA$72.65Secular trend (multi-year)
Monthly10-Month SMA$95.42Near-term monthly trend
Monthly20-Month SMA$82.55Medium-term monthly trend
Monthly40-Month SMA$72.42Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$94.00 support 1.08x 5 months ago
$85.00 support 1.28x 6 months ago
$52.00 support 1.48x 23 months ago

Historical Earnings Reactions (123 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.35% 0.00% 48.78% 8.10% -14.24%
1 Day -0.28% 0.06% 50.41% 11.93% -20.49%
1 Week -1.20% -1.46% 47.15% 22.92% -26.46%
2 Weeks -0.21% -0.51% 48.78% 39.90% -37.22%
1 Month 2.46% -0.55% 48.36% 102.81% -41.86%

Next earnings: July 17, 2026 (49 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan8.4%63.6%33
Feb-0.2%33.3%33
Mar-4.0%42.4%33
Apr-1.0%48.5%33
May6.2%59.4%32
Jun2.4%59.4%32
Jul1.6%53.1%32
Aug1.9%53.1%32
Sep-1.3%40.6%32
Oct2.1%53.1%32
Nov6.1%59.4%32
Dec9.1%57.6%33

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.13% 48.4% 1540
Tuesday 0.02% 47.0% 1683
Wednesday 0.05% 47.5% 1680
Thursday 0.12% 47.8% 1647
Friday 0.31% 50.7% 1642

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 106.6%

Insider Transactions — Smart Summary

Total insider ownership: 1.9%

12-Month Insider Activity Summary

Total Filings34
Net Value-$21.7M
Net Shares Change-378,814
% of Float-0.2%
C-Suite Filings32
Clusters Detected3

Key Insiders

NameTitleNet ValueFilingsActivity
Hoppenot Herve -$19.8M 1 N/A
Morrissey Michael James EVP, Head of Tech. Operations -$5.7M 1 N/A
Stein Steven H EVP and Chief Medical Officer -$5.7M 2 N/A
Issa Mohamed Khairie EVP, Head of US Oncology -$2.1M 1 N/A
Flannelly Barry P EVP and General Manager US -$1.4M 1 N/A
Iyengar Vijay K EVP, GMAPPS -$1.2M 2 N/A
Denton Sheila A. EVP and General Counsel -$707,580.339 2 N/A

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-07-07 – 2025-07-17 9 4 -$4.3M 9 C-suite
2025-11-05 – 2025-11-19 5 4 -$20.1M 4 C-suite
2025-12-12 – 2025-12-22 3 3 -$6.3M 3 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-12-18 Morrissey Michael James EVP, Head of Tech. Operations -$5.7M Transaction at $97.29, now +0.1%
2026-01-08 Issa Mohamed Khairie EVP, Head of US Oncology -$2.1M Transaction at $107.86, now -9.8%
2026-01-07 Stein Steven H EVP and Chief Medical Officer -$1.6M Transaction at $101.70, now -4.3%
2025-12-03 Stein Steven H EVP and Chief Medical Officer -$4.1M Transaction at $102.30, now -4.8%
2025-07-07 Iyengar Vijay K EVP, GMAPPS -$1.1M Transaction at $68.16, now +42.8%
2025-07-07 Flannelly Barry P EVP and General Manager US -$1.4M Transaction at $68.16, now +42.8%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Incyte Corporation (INCY) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for INCY on Trend Edge →